Healthways Coverage Initiated by Analysts at Stephens (HWAY)
Equities researchers at Stephens assumed coverage on shares of Healthways (NASDAQ:HWAY) in a research report issued on Wednesday, TheFlyOnTheWall.com reports. The firm set an “underweight” rating on the stock.
Shares of Healthways (NASDAQ:HWAY) traded down 2.25% on Wednesday, hitting $18.27. The stock had a trading volume of 408,680 shares. Healthways has a 1-year low of $8.58 and a 1-year high of $22.20. The stock’s 50-day moving average is $19.16 and its 200-day moving average is $15.72. The company has a market cap of $628.5 million and a price-to-earnings ratio of 1099.41.
Healthways (NASDAQ:HWAY) last issued its quarterly earnings data on Wednesday, July 24th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.05) by $0.02. The company had revenue of $162.27 million for the quarter, compared to the consensus estimate of $170.30 million. During the same quarter in the previous year, the company posted $0.15 earnings per share. The company’s revenue for the quarter was down 4.7% on a year-over-year basis. On average, analysts predict that Healthways will post $0.22 earnings per share for the current fiscal year.
A number of other firms have also recently commented on HWAY. Analysts at William Blair downgraded shares of Healthways (NASDAQ:HWAY) to a “market perform” rating in a research note to investors on Tuesday, September 24th. Separately, analysts at Thomson Reuters/Verus upgraded shares of Healthways (NASDAQ:HWAY) from a “hold” rating to a “buy” rating in a research note to investors on Monday, September 23rd. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Healthways (NASDAQ:HWAY) in a research note to investors on Monday, September 23rd. They now have a $19.00 price target on the stock. Two analysts have rated the stock with a sell rating, six have issued a hold rating and four have issued a buy rating to the stock. Healthways has a consensus rating of “Hold” and a consensus price target of $16.17.
Healthways, Inc provides solutions to help people improve physical, emotional and social well-being. The Company provides specific and personalized interventions for each individual in a population, irrespective of health status, age or payor.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.